Comment: Senate’s drug-price reforms would limit access
A proposal in the Democrats’ reconcilation bill could force some providers to close or limit medications.
The Cantwell-Grassley PBM Bill is Needed, But More Can Be Done
A proposal could prohibit a PBM from “spread pricing” and “pharmacy clawbacks” unless it passes all rebates and concessions to health plans and discloses important pricing information.
Drug Pricing Plan Faces Industry Gripes as Senate Reconvenes
A new Senate proposal could hinder drugmakers from producing generic version of traditional drugs.
Ty’s Story, a Rare Disease Patient
There are 7,000 rare diseases affecting 25 – 30 million Americans, many of which are children just like Ty.
How a Formulary Change and a Few Tweets Led to a HIPAA Complaint
Patient and patient advocate Beth Waldron used her social media platform to criticize CVS Caremark’s removal of Eliquis (apixaban) from its national formulary. CVS took notice.